Abdullah Ladha

Assistant Professor of Clincial Medicine

Image of Abdullah Ladha
Is this your profile? Click to edit

Publications

  • Stem Cell Mobilization in Multiple Myeloma: Comparing Safety and Efficacy of Cyclophosphamide +/- Plerixafor versus Granulocyte Colony-Stimulating Factor +/- Plerixafor in the Lenalidomide EraTransplant Cell Ther. 2021 07; 27(7):590. e1-590. e8. . View in PubMed
  • Hypomethylating agents are Effective in Treatment for Relapsed Myelofibrosis After Allogeneic Hematopoietic Cell Transplantation Transplant Cell Ther. 2024 Aug 24. . View in PubMed
  • Graft Versus Host Disease Prophylaxis in Matched Donor Stem Cell Transplantation: Post-transplantation Cyclophosphamide Combinations Versus Methotrexate/Tacrolimus Transplant Proc. 2024 Aug 21. . View in PubMed
  • Impact of Prior Inotuzumab Ozogamicin Treatment on Brexucabtagene Autoleucel outcomes in Adults with B-cell ALL Blood Adv. 2024 Aug 02. . View in PubMed
  • Donor matters: Donor selection impact on hematopoietic stem cell transplantation outcomes in Hispanic patients with B-cell acute lymphocytic leukemia: Insights from a myeloablative HSCT study Leuk Res. 2024 Jun; 141:107501. . View in PubMed
  • Post-stem cell transplant maintenance in FLT3mut acute myeloid leukemia – A retrospective analysis: Outcomes are improved with midostaurin but not with gilteritinib EJHaem. 2024 Apr; 5(2):423-427. . View in PubMed
  • Concordance of Next-Generation Sequencing and Multiparametric Flow Cytometry Methods for Detecting Measurable Residual Disease in Adult Acute Lymphoblastic Leukemia: Optimizing Prediction of Clinical Outcomes From a Single-Center StudyClin Lymphoma Myeloma Leuk. 2024 03; 24(3):e59-e66. e2. . View in PubMed
  • Case report: Pulse cyclophosphamide for treatment of multi-agent-refractory hepatic graft-versus-host disease Front Oncol. 2024; 14:1329893. . View in PubMed
  • Real world experience: Examining outcomes using letermovir for CMV prophylaxis in high-risk allogeneic hematopoietic stem cell patients in the setting of using T-cell depletion as GVHD prophylaxis Transpl Immunol. 2023 02; 76:101769. . View in PubMed
  • Unique challenges to diagnosing sweet syndrome following induction chemotherapy for relapsed Acute Myeloid Leukemia (AML): A case and brief-review Respir Med Case Rep. 2023; 46:101922. . View in PubMed
  • Leuk Lymphoma. 2021 06; 62(6):1510-1513. . View in PubMed
  • Hepatic veno-occlusive disease in allogeneic stem cell transplant recipients with prior exposure to gemtuzumab ozogamicin or inotuzumab ozogamicin Leuk Lymphoma. 2021 02; 62(2):257-263. . View in PubMed
  • Mantle cell lymphoma and its management: where are we now? Exp Hematol Oncol. 2019; 8:2.. View in PubMed
  • What is the Personal Immune Price for Hospice Caregivers? A Case-Control Study. Arch Palliat Care Med. 2018; 2(2).. View in PubMed
  • Clinical Resolution of Red Cell Aplasia Associated del 17p Multiple Myeloma, When Treated With Bortezomib and Dexamethasone J Hematol. 2018 Jan; 7(1):29-31. . View in PubMed
  • Care of the frail elder: the nexus of geriatrics and palliative care Minn Med. 2013 Apr; 96(4):39-42. . View in PubMed
  • The health seeking behaviour of elderly population in a poor-urban community of Karachi, Pakistan J Pak Med Assoc. 2009 Feb; 59(2):89-92. . View in PubMed
  • Response of Imitanib Meysylate in patients with gastrointestinal stromal cell tumour J Pak Med Assoc. 2008 Dec; 58(12):696-7. . View in PubMed
  • Primary renal lymphoma J Coll Physicians Surg Pak. 2008 Sep; 18(9):584-5. . View in PubMed